A multicenter, postmarketing study to evaluate the concentration of certolizumab pegol in the breast milk of mothers receiving treatment with Cimzia® (certolizumab pegol) (CRADLE) First published 24/06/2014 Last updated 02/07/2024 EU PAS number:EUPAS6785 Study Finalised